Evidence map›Paper›PMID 29600034›Full record

ArticleJournal of thoracic disease2018

Examining the paradox of high high-density lipoprotein and elevated cardiovascular risk.

Kavisha Singh, Anand Rohatgi

Abstract readEditorialComment
In one paragraph

Article in Journal of thoracic disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. HDL Is Not Dead Yet.Biomedicines · 2022
    Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Kavisha SinghDivision of Cardiology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA.
Anand RohatgiDivision of Cardiology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA.

Funding

The Genetic and Molecular Basis of Cholesterol EffluxR01HL136724 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI ROHATGI, ANAND KUMAR · 2018 to 2022
$3.8M
Moving Beyond HDL Cholesterol, HDL Function as a Coronary Disease BiomarkerK08HL118131 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI ROHATGI, ANAND KUMAR · 2013 to 2017
$665k
American Heart Association-American Stroke Association 15CVGPSD27030013NHLBI NIH HHS K08 HL118131NHLBI NIH HHS R01 HL136724
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID29600034
PMCPMC5863140

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.